Inappropriate expression of hepcidin is associated with iron refractory anemia: Implications for the anemia of chronic disease

Blood

Volumn 100, Issue 10, 2002, Pages 3776-3781

  Weinstein, David A ^a,b   Roy, Cindy N ^a,b   Fleming, Mark D ^a,b   Loda, Massimo F ^a,b   Wolfsdorf, Joseph I ^a,b   Andrews, Nancy C ^a,b,c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

^c BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; ERYTHROPOIETIN; HEMOGLOBIN; HEPCIDIN; INTERLEUKIN 13; INTERLEUKIN 16; IRON; IRON DEXTRAN; MESSENGER RNA; NATURAL RESISTANCE ASSOCIATED MACROPHAGE PROTEIN 2; PEPTIDE; TRANSFERRIN; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ECHOGRAPHY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; INFANT; IRON DEFICIENCY ANEMIA; LIVER ADENOMA; LIVER TRANSPLANTATION; MALE; MOUSE; NONHUMAN; NORTHERN BLOTTING; NUCLEAR MAGNETIC RESONANCE IMAGING; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0037111732     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2002-04-1260     Document Type: Article

References (26)

1. Means RT Jr. The anaemia of infection. Baillieres Best Pract Res Clin Haematol. 2000;13:151-162.
2. Lee GR. The anemia of chronic disease. Semin Hematol. 1983;20:61-80.
3. Cortell S, Conrad ME. Effect of endotoxin on iron absorption. Am J Physiol. 1967;213:43-47.
4. Weinberg ED. Iron depletion: A defense against intracellular infection and neoplasia. Life Sci, 1992;50:1289-1297.
5. Jurado RL. Iron, infections and anemia of inflammation. Clin Infect Dis. 1997;25:888-895.
6. Moldawer LL, Marano MA, Wei H, et al. Cachectin/tumor necrosis factor-α alters red blood cell kinetics and induces anemia in vivo. FASEB J. 1989;3:1637-1643.
7. Weiss G. Iron and anemia of chronic disease. Kidney Int Suppl. 1999;69:S12-S17.
8. Means RT. Pathogenesis of the anemia of chronic disease: A cytokine-mediated anemia. Stem Cells. 1995;13:32-37.
9. Fleming RE, Sly WS. Hepcidin: A putative iron-regulatory hormone relevant to hereditary hemochromatosis and the anemia of chronic disease. Proc Natl Acad Sci U S A. 2001;98:8160-8162.
10. Park CH, Valore EV, Waring AJ, Ganz T. Hepcidin, a urinary antimicrobial peptide synthesized in the liver. J Biol Chem. 2001;276:7806-7810.
11. Krause A, Neitz S, Magert HJ, et al. LEAP-1, a novel highly disulfide-bonded human peptide, exhibits antimicrobial activity. FEBS Lett. 2000;480:147-150.
12. Pigeon C, Ilyin G, Courselaud B, et al. A new mouse liver-specific gene, encoding a protein homologous to human antimicrobial peptide hepcidin, is overexpressed during iron overload. J Biol Chem. 2001;276:7811-7819.
13. Nicolas G, Bennoun M, Porteu A, et al. Severe iron deficiency anemia in transgenic mice expressing liver hepcidin. Proc Natl Acad Sci U S A. 2002;99:4596-4601.
14. Nicolas G, Bennoun M, Devaux I, et al. Lack of hepcidin gene expression and severe tissue iron overload in upstream stimulatory factor 2 (USF2) knockout mice. Proc Natl Acad Sci U S A. 2001;98:8780-8785.
15. Chen Y-T. Glycogen storage diseases. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The Metabolic and Molecular Bases of Inherited Disease. 8th Ed. New York, NY: McGraw-Hill; 2001:1521-1551.
16. Talente GM, Coleman RA, Alter C, et al. Glycogen storage disease in adults. Ann Intern Med. 1994;120:218-226.
17. Weinstein DA, Wolfsdorf JI. Effect of continuous glucose therapy with uncooked cornstarch on the long-term clinical course of type 1 a glycogen storage disease. Eur J Pediatr. Prepublished online July 31, 2002; DOI 10.1007/S00431-002-1000-2.
18. Torrance JD, Bothwell TH. Tissue iron stores. In: Cook JD, ed. Methods in Hematology. Vol 1. New York, NY: Churchill Livingstone Press; 1980:104-109.
19. Galaktionov K, Lee AK, Eckstein J, et al. CDC25 phosphatases as potential human oncogenes. Science. 1995;269:1575-1577.
20. Andrews NC. Iron homeostasis: Insights from genetics and animal models. Nat Rev Genet. 2000;1:208-217.
21. Vulpe CD, Kuo YM, Murphy TL, et al. Hephaestin, a ceruloplasmin homologue implicated in intestinal iron transport, is defective in the sla mouse. Nat Genet. 1999;21:195-199.
22. Fleming MD, Trenor CCI, Su MA, et al. Microcytic anemia mice have a mutation in Nramp2, a candidate iron transporter gene. Nat Genet. 1997;16:383-386.
23. Trenor CC, Campagna DR, Sellers VM, Andrews NC, Fleming MD. The molecular defect in hypotransferrinemic mice. Blood. 2000;96:1113-1118.
24. Andrews NC. Medical progress: Disorders of iron metabolism. N Engl J Med. 1999;341:1986-1995.
25. Shike H, Lauth X, Westerman ME, et al. Bass hepcidin is a novel antimicrobial peptide induced by bacterial challenge. Eur J Biochem. 2002;269:2232-2237.
26. Means RT Jr. Advances in the anemia of chronic disease. Int J Hematol. 1999;70:7-12.